Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
63 participants
INTERVENTIONAL
2009-02-28
2013-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Flavonoids on Cognitive Performance in Healthy Young Adults
NCT01312597
The Effects of Flavonoid Supplementation on Cognition and Neural Mechanisms in Healthy Older Adults
NCT03030053
Effects of Acute Intake of Flavanols on Cerebral Oxygenation and Cognition in Young Male Adults
NCT04374409
Effect of Polyphenol-rich Cocoa Products on Cognitive Function
NCT02996578
Effects of a Cocoa Shot on the Human Brain
NCT01924481
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High Flavanol
High Flavanol cocoa drink containing 495mg cocoa
Cocoa Drink
High Flavanol (495mg) Low Flavanol (23mg) Matched for macro and micro nutrients
Low Flavanol
Low Flavanol cocoa drink (23mg)
Cocoa Drink
High Flavanol (495mg) Low Flavanol (23mg) Matched for macro and micro nutrients
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cocoa Drink
High Flavanol (495mg) Low Flavanol (23mg) Matched for macro and micro nutrients
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* A signed consent form
Exclusion Criteria
* Haemoglobin (anaemia marker) \< 125 g/l
* Gamma GT (liver enzymes) \> 80 IU/l
* Had suffered a myocardial infarction or stroke in the previous 12 months
* Suffers from any gastrointestinal/stomach disorder
* Suffers from any blood-clotting disorder
* On medication for hypertension
* Suffers from any metabolic disorders (e.g. diabetes or any other endocrine or liver diseases)
* Depression or major mental illness
* Any dietary restrictions or on a weight reducing diet
* Drinking more than 21 units per week
* On any medication affecting blood clotting
* Smoking
* Vegans
60 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Reading
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jeremy Paul Edward Spencer
Professor of Nutritional Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jeremy Spencer, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Reading
Laurie Butler, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Reading
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Reading
Reading, Berkshire, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UReading-2011-02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.